Palisade Bio, Inc.
PALI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,336 | $60,534 | $68,647 | $181,540 |
| - Cash | $9,821 | $12,432 | $12,383 | $10,495 |
| + Debt | $169 | $369 | $404 | $199 |
| Enterprise Value | -$7,316 | $48,471 | $56,668 | $171,244 |
| Revenue | $0 | $250 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $250 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$14,423 | -$12,281 | -$14,244 | -$24,216 |
| % Margin | – | -4,912.4% | – | – |
| Net Income | -$14,438 | -$12,300 | -$14,260 | -$26,616 |
| % Margin | – | -4,920% | – | – |
| EPS Diluted | -10.19 | -27.01 | -16.53 | -2,546.1 |
| % Growth | 62.3% | -63.4% | 99.4% | – |
| Operating Cash Flow | -$12,193 | -$11,133 | -$13,360 | -$14,773 |
| Capital Expenditures | $0 | -$4 | -$10 | $0 |
| Free Cash Flow | -$12,193 | -$11,137 | -$13,370 | -$14,773 |